Emcure Pharmaceuticals Ltd share price logo

Emcure Pharmaceuticals Ltd

NSE: EMCURE

BSE: 544210

Small Cap

Pharma Sector

₹1755.10

-11.50

(-0.65%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

What are INDmoney investors doing with Emcure Pharmaceuticals shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-31%

Searches for Emcure Pharmaceuticals on INDmoney have decreased by 31% over the last 30 days.

Average holding period of indmoney investors

23 days

INDmoney investors hold Emcure Pharmaceuticals shares for an average of 23 days.

Key Events for Emcure Pharmaceuticals

Upcoming Events

Next Results Date
03/11/2026

Last Dividend Declared

₹3.60 per share, declared on 05/05/2026

View Dividend History

Emcure Pharmaceuticals Stock Performance

as on October 21, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,725.10
    ₹1,778.90
    downward going graph

    1.71%

    Downside

    1.36%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹1,306.50
    ₹2,100.70
    downward going graph

    25.56%

    Downside

    19.69%

    Upside

    downward going graph

Emcure Pharmaceuticals share price movements today

Previous Close
₹1,766.60
Open
₹1,770.00
Volume
94.22K
Upper Circuit
₹1,943.20
Lower Circuit
₹1,590.00
Day's Low - High
₹1,725.10 - ₹1,778.90
52 Week Low - High
₹1,306.50 - ₹2,100.70

Emcure Pharmaceuticals Historical Returns

1 Month Return
-12.08 %
3 Month Return
-8.2 %
1 Year Return
+ 26.82 %
3 Year Return
+ 29.98 %
5 Year Return
+ 29.98 %

Emcure Pharmaceuticals Fundamentals

as on October 21, 2026 at 4:01 pm IST

Market Cap

₹33,514.28 Cr

Return on Equity (ROE)

21.77

PE Ratio (TTM)

33.11

Return on capital employed (ROCE)

22.83

Industry PE ratio

50.28

Beta (LTM)

0.43

P/B Ratio

8.15

Dividend Yield

0.23

PEG Ratio

2.35

Quarterly Earnings Growth YOY

36.17

EPS (TTM)

49.65

Book Value

261.09

Emcure Pharmaceuticals Stock Valuation

as on October 21, 2026 at 4:01 pm IST

Emcure Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (24.97x)

April 9, 2025

Today (33.11x)

October 19, 2026

Industry (50.28x)

October 19, 2026

Highest (53.98x)

September 18, 2024

LowHigh

Today’s Price to Earnings Ratio: 33.11x

Emcure Pharmaceuticals Technical Analysis

Track how Emcure Pharmaceuticals technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish1
Bullish11
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
1.01
Bearish
CCI (20)
-314.14
Bullish
RSI (14)
61.31
Neutral
Momentum (10)
1.5
Bullish
ADI (14)
18.19
Neutral
Ultimate Oscillator (7,14,28)
59.93
Neutral

Moving Averages

Name

Value

Action

SMA (20)
1758.63
Bullish
EMA (20)
1758.34
Bullish
VWMA (20)
1758.89
Bullish
SMA (50)
1755.79
Bullish
EMA (50)
1756.13
Bullish
SMA (200)
1742.59
Bullish
EMA (200)
1748.69
Bullish
KAMA (200)
1754.93
Bullish
DEMA (200)
1749.91
Bullish

Emcure Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Emcure Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY33,514.286%0.639419,203
NA136.993.95%0.0010106
NA17.81-3.54%0.00-246
NA4,596.02363.96%0.61221801
BUY406.4418.95%0.0034168

Market expectation of Emcure Pharmaceuticals Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Emcure Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
1,667.64
1,771.36
1,815.14
2,001.98
1,962.63
2,116.25
2,100.54
2,269.82
2,363.48
2,469.7
2,580.45
Other Income
28.94
11.74
23.44
35.65
3.9
4.45
3.7
3.12
1.85
14.29
2.07
Total Income
1,696.58
1,783.1
1,838.58
2,037.64
1,966.53
2,120.7
2,104.23
2,272.95
2,365.33
2,484
2,582.52
Expenses
1,380.59
1,460.14
1,478.82
1,621.11
1,608.02
1,724.22
1,687.26
1,794.34
1,908.88
1,990.15
2,047.95
Operating Profit
287.05
311.22
336.32
380.87
354.61
392.03
413.28
475.48
454.6
479.55
532.5
Operating Profit Margin %
17.21%
17.57%
18.53%
19.02%
18.07%
18.52%
19.67%
20.95%
19.23%
19.42%
20.64%
Profit Before Interest, Tax and Depreciation
316
322.95
359.76
416.53
358.5
396.48
416.97
478.6
456.45
493.84
534.57
Interest
60.65
65.49
58.76
46.22
31.78
39.03
26.76
32.54
37.98
46.4
31.54
Depreciation
84.39
90.56
93.59
96.9
96.81
96.84
99.46
104.64
104.68
106.27
109.51
Profit Before Tax
170.96
166.9
207.41
273.41
229.91
260.61
290.75
341.42
313.79
341.17
393.52
Tax Paid
51.2
45.89
54.82
71.86
73.83
63.37
75.97
90.05
82.42
97.44
101.03
Profit After Tax
119.76
121.02
152.59
201.55
156.09
197.24
214.79
251.37
231.37
243.74
292.49
Total Net profit including share of profit / Loss from associate company
119.76
121.02
152.59
201.55
156.09
197.24
214.79
251.37
231.37
243.74
292.49
EPS
6.27
6.36
7.95
10.23
8.12
9.97
10.92
12.85
12.16
12.84
15.5
Actual EPS
6.27
6.36
7.95
10.23
8.12
9.97
10.92
12.85
12.16
12.84
15.5
Adjusted EPS
6.27
6.36
7.95
10.23
8.12
9.97
10.92
12.85
12.16
12.84
15.5
Diluted EPS
6.27
6.36
7.95
10.23
8.12
9.97
10.92
12.85
12.16
12.84
15.5

Emcure Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
4,717.18
5,048.55
6,056.42
5,855.39
5,985.81
6,658.25
7,896
9,203.54
Other Income
98.41
82.31
35.39
63.47
45.91
56.99
67.26
12.66
Total Income
4,815.59
5,130.86
6,091.81
5,918.86
6,031.72
6,715.24
7,963.26
9,216.2
Expenses
3,956.82
4,448.09
4,913.04
4,525.48
4,810.78
5,438.46
6,432
7,370.34
Operating Profit
760.36
600.46
1,143.38
1,329.91
1,175.03
1,219.79
1,464
1,833.2
Operating Profit Margin %
16.12%
11.89%
18.88%
22.71%
19.63%
18.32%
18.54%
19.92%
Profit Before Interest, Tax and Depreciation
858.77
682.77
1,178.77
1,393.38
1,220.94
1,276.78
1,531.26
1,845.86
Interest
236.36
256.6
198.13
175.98
213.61
237.15
175.78
143.67
Depreciation
299.78
320.83
323.31
244.86
260.12
312.41
384.13
415.05
Profit Before Tax
322.63
105.34
657.33
972.54
747.21
727.22
971.35
1,287.14
Tax Paid
119.67
4.73
238.73
269.99
185.37
199.65
263.88
345.87
Profit After Tax
202.97
100.61
418.59
702.56
561.85
527.58
707.47
941.27
Total Net profit including share of profit / Loss from associate company
202.97
100.61
418.59
702.56
561.85
527.58
707.47
941.27
EPS
10.47
4.62
21.68
36.62
29.42
27.54
36.43
48.77
Actual EPS
10.47
4.62
21.68
36.62
29.42
27.54
36.43
48.77
Adjusted EPS
10.47
4.62
21.68
36.62
29.42
27.54
36.43
48.77
Diluted EPS
10.47
4.62
21.68
36.62
29.42
27.54
36.43
48.77

Emcure Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
482.31
444.24
500.3
704.44
768.21
746.85
1,097.24
851.71
943.55
Cash Flow from Investing Activities
-426.33
-408.77
-167.94
-256.47
-549.49
-467.81
-714.5
-96.06
-1,174.9
Cash Flow from Financing Activities
-68.5
-735.07
-300.51
-188.9
-151.85
-145.39
-164.22
-813.96
343.43
Net Cash Flow
-12.51
-699.61
31.86
259.07
41.87
133.64
218.52
-58.3
112.08

Emcure Pharmaceuticals Stock Shareholding Pattern

Numbers in percentages

Jul 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Promoters
78.08%
78.08%
77.94%
77.92%
77.91%
77.88%
77.87%
77.87%
77.83%
77.82%
DII
3%
3.96%
3.87%
3.44%
2.84%
4.37%
6.1%
6.1%
8.46%
8.49%
FII
0%
2.91%
3.05%
3.07%
2.86%
3.29%
3.59%
3.35%
4.88%
4.94%
Public
16.82%
15.05%
15.14%
15.57%
16.39%
14.46%
12.44%
12.69%
8.83%
8.75%
Total Outstanding Shares
18,90,98,347
18,90,98,347
18,94,31,847
18,94,83,347
18,95,08,347
18,95,64,847
18,95,72,547
18,95,89,547
18,96,80,147
18,97,10,647
Total Shareholders
4,98,006
1,52,914
1,43,449
1,39,671
1,33,549
1,26,169
1,18,863
1,22,189
1,24,991
1,29,328

Mutual Funds Buying / Exiting Emcure Pharmaceuticals

Holdings as of 15 Oct 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Emcure Pharmaceuticals

Sorted by largest increase in holding, month-over-month.

No buying activity data available right now

No buying activity data available right now

Mutual Funds Exiting Emcure Pharmaceuticals

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

Nippon India Multi Cap Fund - Direct Plan - Growth

Nippon India Multi Cap Fund - Direct Plan - Growth

₹271.56 Cr

₹15.30 Cr (-5.33%)

0.56%

Emcure Pharmaceuticals Corporate Actions

View detailed summary of the earnings and dividend history of Emcure Pharmaceuticals.

  • Emcure Pharmaceuticals Ltd Earnings Results

    Emcure Pharmaceuticals Ltd’s net profit jumped 42.05% since last year same period to ₹293.98Cr in the Q1 2026-2027. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated 20.78% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Emcure Pharmaceuticals Ltd Dividends May,2026

    In the quarter ending March 2026, Emcure Pharmaceuticals Ltd has declared dividend of ₹3.60 per share on 05 May 2026 - translating a dividend yield of 0.20%.

    Read More about Dividends

Indices Featuring Emcure Pharmaceuticals Stock

Check stock indices that include Emcure Pharmaceuticals.

S&P BSE 400 MidSmallCap

₹11,735.60

-212.53 (▲1.78%)

Nifty MidSmallcap 400

₹19,705.05

-340.20 (▲1.70%)

Nifty Smallcap 250

₹17,041.95

-393.20 (▲2.26%)

BSE Healthcare

₹47,363.53

-401.13 (▲0.84%)

BSE 500

₹34,154.32

-326.93 (▲0.95%)

S&P BSE 250 SmallCap

₹6,679.35

-147.52 (▲2.16%)

Nifty 500

₹21,837.90

-203.70 (▲0.92%)

Insights on Emcure Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 3.35% to 4.88% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 4.94% to 6.87% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 77.87% to 77.83% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 12.69% to 8.83% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, EMCURE stock has moved down by -5.3%

About Emcure Pharmaceuticals Ltd



Revenue: ₹2,580.45Cr as on June 2026 (Q1 FY27)
Net Profit: ₹292.49Cr as on June 2026 (Q1 FY27)
Listing date: 10 Jul, 2024
OrganisationEmcure Pharmaceuticals Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Emcure Pharmaceuticals share price today?

Emcure Pharmaceuticals share price today stands at ₹1755.1 as on at the close of the market. Emcure Pharmaceuticals share today touched a day high of ₹1778.9 and a low of ₹1725.1.

What is the 52 week high and 52 week low range for Emcure Pharmaceuticals share?

Emcure Pharmaceuticals touched a 52 week high of ₹2100.7 and a 52 week low of ₹1306.5. Emcure Pharmaceuticals share price today i.e. is closed at ₹1755.1, which is -16.45% down from its 52 week high and 34.34% up from its 52 week low.

What is Emcure Pharmaceuticals's market capitalisation today?

Emcure Pharmaceuticals market capitalisation is ₹33,514.28 Cr as on .

How to buy Emcure Pharmaceuticals shares?

To buy Emcure Pharmaceuticals shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for EMCURE or Emcure Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Emcure Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Emcure Pharmaceuticals trading volume today?

Emcure Pharmaceuticals trading volume is 94.22K as on . This means that 94.22K shares of Emcure Pharmaceuticals were bought and sold on the stock market during today's trading session.